Jpmorgan Chase & CO Zai Lab LTD Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Zai Lab LTD stock. As of the latest transaction made, Jpmorgan Chase & CO holds 244,522 shares of ZLAB stock, worth $7.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

244,522

Previous 43,922 456.72%

Holding current value

$7.54 Million

Previous $703,000 502.7%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$13.72 - $21.55 $2.75 Million - $4.32 Million	200,600 Added 456.72%	244,522 $4.24 Million
Q1 2024 May 10, 2024	BUY	$15.95 - $26.8 $48,456 - $81,418	3,038 Added 7.43%	43,922 $703,000
Q4 2023 Feb 12, 2024	SELL	$22.97 - $30.58 $4.44 Million - $5.91 Million	-193,402 Reduced 82.55%	40,884 $1.12 Million
Q3 2023 Nov 14, 2023	BUY	$22.72 - $31.49 $915,275 - $1.27 Million	40,285 Added 20.77%	234,286 $5.7 Million
Q2 2023 Aug 11, 2023	SELL	$25.3 - $39.67 $2.31 Million - $3.63 Million	-91,489 Reduced 32.05%	194,001 $5.38 Million
Q1 2023 May 11, 2023	BUY	$30.21 - $48.1 $5.86 Million - $9.33 Million	194,063 Added 212.26%	285,490 $9.5 Million
Q4 2022 Feb 13, 2023	SELL	$22.28 - $38.71 $2.49 Million - $4.33 Million	-111,745 Reduced 55.0%	91,427 $2.81 Million
Q3 2022 Nov 14, 2022	SELL	$34.2 - $51.69 $1.25 Million - $1.89 Million	-36,638 Reduced 15.28%	203,172 $6.95 Million
Q2 2022 Aug 11, 2022	SELL	$23.14 - $49.68 $1.18 Million - $2.53 Million	-50,939 Reduced 17.52%	239,810 $8.32 Million
Q1 2022 May 11, 2022	SELL	$27.77 - $64.4 $3.62 Million - $8.39 Million	-130,221 Reduced 30.93%	290,749 $12.8 Million
Q4 2021 Feb 10, 2022	SELL	$54.9 - $105.21 $2.24 Million - $4.3 Million	-40,835 Reduced 8.84%	420,970 $26.5 Million
Q3 2021 Nov 12, 2021	BUY	$105.0 - $178.37 $48.5 Million - $82.4 Million	461,805 New	461,805 $48.7 Million

Others Institutions Holding ZLAB

# of Institutions

116

Shares Held

40.8M

Call Options Held

63.1K

Put Options Held

420K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.02B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Zai Lab LTD Transaction History